MENU
KNSA
AS OF
Nov 13, 04:59 PM (EDT)
Price
$40.29
Change
-$0.29 (-0.71%)
Capitalization
3.08B
110 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
KNSA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kiniksa Pharmaceuticals International (KNSA) Earnings Date & Reports

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases... Show more

A.I. Advisor
published Earnings

KNSA is expected to report earnings to rise 74.78% to 40 cents per share on March 03

Kiniksa Pharmaceuticals International KNSA Stock Earnings Reports
Q4'25
Est.
$0.40
Q3'25
Missed
by $0.09
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.14
The last earnings report on October 28 showed earnings per share of 23 cents, missing the estimate of 31 cents. With 75.75K shares outstanding, the current market capitalization sits at 3.08B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
KNSA
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KNSA showed earnings on October 28, 2025. You can read more about the earnings report here.
View AI-Driven Trading for KNSA
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Church Street
Phone
+44 8081896257
Employees
297
Web
https://www.kiniksa.com